CIBINQO

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 393725ca9079b0db
Drug Approval Canada Name: CIBINQO
Product Name: CIBINQO
Status: Marketed
Status Date: 2022-09-29
Original Market Date: 2022-09-29
Din: 02528363
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:24.00
Atc Original: D11AH08 ABROCITINIB
Atc Name: d 11 ah 08
Aig Number: 0163862001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

ABROCITINIB

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

393725ca9079b0db

Type

Standard